• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Corrigendum to "Berberine derivative DCZ0358 induced oxidative damage by ROS-mediated JNK signaling in DLBCL cells" [Int. Immunopharmacol. 125(Part A) (2023) 111139].

作者信息

Feng Qilin, Hu Ke, Hu Huifang, Lu Yumeng, Zhang Hui, Wang Guanli, Zhang Qikai, Xu Zhijian, Gao Xuejie, Jia Xinyan, Zhu Huabin, Song Dongliang, Yi Hongfei, Peng Yu, Wu Xiaosong, Li Bo, Zhu Weiliang, Shi Jumei

机构信息

Department of Hematology, Shanghai East Hospital, Tongji University School of Medicine, Shanghai 200120, China.

State Key Laboratory of Drug Research, Drug Discovery and Design Center, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China.

出版信息

Int Immunopharmacol. 2024 Aug 20;137:112499. doi: 10.1016/j.intimp.2024.112499. Epub 2024 Jun 21.

DOI:10.1016/j.intimp.2024.112499
PMID:38909009
Abstract
摘要

相似文献

1
Corrigendum to "Berberine derivative DCZ0358 induced oxidative damage by ROS-mediated JNK signaling in DLBCL cells" [Int. Immunopharmacol. 125(Part A) (2023) 111139].对“小檗碱衍生物DCZ0358通过ROS介导的JNK信号通路在弥漫性大B细胞淋巴瘤细胞中诱导氧化损伤”[《国际免疫药理学》125（A部分）（2023）111139]的勘误
Int Immunopharmacol. 2024 Aug 20;137:112499. doi: 10.1016/j.intimp.2024.112499. Epub 2024 Jun 21.
2
Berberine derivative DCZ0358 induce oxidative damage by ROS-mediated JNK signaling in DLBCL cells.小檗碱衍生物 DCZ0358 通过 ROS 介导的 JNK 信号通路诱导弥漫性大 B 细胞淋巴瘤细胞氧化损伤。
Int Immunopharmacol. 2023 Dec;125(Pt A):111139. doi: 10.1016/j.intimp.2023.111139. Epub 2023 Oct 30.
3
Corrigendum to "Berberine regulates PADI4-related macrophage function to prevent lung cancer" [Int. Immunopharmacol. 110 (2022) 108965].《小檗碱调节与PADI4相关的巨噬细胞功能以预防肺癌》的勘误 [《国际免疫药理学》110 (2022) 108965]
Int Immunopharmacol. 2023 Jul;120:110366. doi: 10.1016/j.intimp.2023.110366. Epub 2023 May 29.
4
Corrigendum to "In vivo anti-apoptosis activity of novel berberine-loaded chitosan nanoparticles effectively ameliorates osteoarthritis" [Int. Immunopharmacol. 28(1) (2015) 34-43].《新型载黄连素壳聚糖纳米粒的体内抗凋亡活性有效改善骨关节炎》的勘误[《国际免疫药理学》28(1)(2015)34 - 43]
Int Immunopharmacol. 2022 Jul;108:108844. doi: 10.1016/j.intimp.2022.108844. Epub 2022 May 11.
5
Corrigendum to "In vivo anti-apoptosis activity of novel berberine-loaded chitosan nanoparticles effectively ameliorates osteoarthritis" [Int. Immunopharmacol. 28(1) (2015) 34-43].《新型载黄连素壳聚糖纳米粒的体内抗凋亡活性有效改善骨关节炎》的勘误[《国际免疫药理学》28(1)(2015)34 - 43]
Int Immunopharmacol. 2020 Sep;86:106796. doi: 10.1016/j.intimp.2020.106796. Epub 2020 Jul 14.
6
Corrigendum to "Anti-arthritis effect of berberine associated with regulating energy metabolism of macrophages through AMPK/HIF-1α pathway". [Int. Immunopharmacol. 87 (2020) 106830].《黄连素通过AMPK/HIF-1α途径调节巨噬细胞能量代谢发挥抗关节炎作用》勘误 [《国际免疫药理学》87卷（2020年）106830页]
Int Immunopharmacol. 2021 Oct;99:107911. doi: 10.1016/j.intimp.2021.107911. Epub 2021 Aug 2.
7
Corrigendum to 'In-vitro and in-vivo anti-breast cancer activity of synergistic effect of berberine and exercise through promoting the apoptosis and immunomodulatory effects' [Int. Immunopharmacol. 87 (2020) 106787].《小檗碱与运动协同作用通过促进细胞凋亡和免疫调节作用的体外和体内抗乳腺癌活性》的勘误[《国际免疫药理学》87卷（2020年）106787]
Int Immunopharmacol. 2020 Nov;88:106899. doi: 10.1016/j.intimp.2020.106899. Epub 2020 Aug 19.
8
Corrigendum to "BRG1 alleviates microglial activation by promoting the KEAP1-NRF2/HO-1 signaling pathway and minimizing oxidative damage in cerebral ischemia-reperfusion" [Int. Immunopharmacol. 119 (2023) 110201].
Int Immunopharmacol. 2024 Mar 10;129:111541. doi: 10.1016/j.intimp.2024.111541. Epub 2024 Feb 1.
9
Retraction notice to "Corrigendum to "MLL1 promotes migration and invasion of fibroblast-like synoviocytes in rheumatoid arthritis by activating the TRIF/NF-κB signaling pathway via H3K4me3 enrichment in the TLR4 promoter region"" [Int. Immunopharmacol. 82 (2020) 106220] [Int. Immunopharmacol. 92 (2021) 107321].撤回对“《对‘MLL1通过在TLR4启动子区域富集H3K4me3激活TRIF/NF-κB信号通路促进类风湿性关节炎中成纤维样滑膜细胞迁移和侵袭’的勘误》”的通知 [《国际免疫药理学》82卷（2020年）第106220页] [《国际免疫药理学》92卷（2021年）第107321页] 。
Int Immunopharmacol. 2023 Apr;117:109865. doi: 10.1016/j.intimp.2023.109865. Epub 2023 Feb 21.
10
Corrigendum to "Oridonin regulates the polarized state of Kupffer cells to alleviate nonalcoholic fatty liver disease through ROS-NF-κB" [Int. Immunopharmacol. 101(Part B) (2021) 108290].《冬凌草甲素通过ROS-NF-κB调节库普弗细胞极化状态以减轻非酒精性脂肪性肝病》的勘误 [《国际免疫药理学》101(Part B) (2021) 108290]
Int Immunopharmacol. 2023 Jun;119:110302. doi: 10.1016/j.intimp.2023.110302. Epub 2023 May 14.